Immatics NV (IMTX)
7.13
+0.40
(+5.94%)
USD |
NASDAQ |
Oct 19, 15:33
Immatics Cash from Operations (Annual) : -199.34M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -199.34M |
| December 31, 2024 | -170.94M |
| December 31, 2023 | 19.71M |
| December 31, 2022 | 105.24M |
| Date | Value |
|---|---|
| December 31, 2021 | -96.67M |
| December 31, 2020 | -97.59M |
| December 31, 2019 | 76.16M |
| December 31, 2018 | 8.946M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| BioNTech SE | 514.63M |
| MediGene AG | -- |
| InflaRx NV | -39.86M |
| Twist Bioscience Corp. | -47.63M |
| Prime Medicine, Inc. | -162.56M |